GDRX

GoodRx Holdings, Inc.

GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different sources. Its platform also provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, HeyDoctor and the GoodRx Telehealth Marketplace, and other healthcare related content. Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee. Its pharmaceutical manufacturer solutions offering provides advertising and integrated consumer affordability solutions to pharmaceutical manufacturers.

GoodRx Holdings, Inc. (GDRX) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B); its weakest is Growth (D+). The rating has held at C+ for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.7 / 5.0
C+
Value
C
Factor Score 2.4 / 5.0
Growth
D+
Factor Score 1.8 / 5.0
Profitability
B
Factor Score 3.2 / 5.0
Momentum
B
Factor Score 3.4 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 73.0
EV / EBITDA 13.7
Rev Growth YoY -1.3%
Gross Margin 90.8%
Price Return 3M -1.9%
Price Return 12M 19.3%
Catalyst Signal 0.00
Market Cap $1.2B
TTM Revenue $785.2M
Price / Sales 1.6
ROE 2.5%

Historical Factor Score Progression

Held C+ for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 C (2.4) D+ (1.8) B (3.2) B (3.4) C+ (2.6) C+ (2.7)
2026-11-05 C (2.4) D+ (1.8) B (3.2) B (3.3) C+ (2.7) C+ (2.7)
2026-10-29 C (2.5) D+ (1.8) B- (3.1) B (3.4) C+ (2.7) C+ (2.7)
2026-10-22 C (2.5) D+ (1.8) B- (3.1) B+ (3.6) C+ (2.6) C+ (2.7)
2026-10-15 C+ (2.6) D+ (1.8) B- (3.1) B (3.4) C+ (2.6) C+ (2.7)
Page 1 of 8
…